Literatur
- 1 Deutsche Stiftung für Organtransplantation .Organspende und Transplantation, Deutschland
1999. Neu-Isenburg: DSO 2000
- 2 UNAIDS .Epidemic update - Report on the global HIV/AIDS epidemic, December 2000.
http://www.unaids.org/epidemic_update/report_dec00/index_dec.html.
- 3
Hughes W T, Armstrong D, Bodey G P. et al .
Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained
fever.
J Infect Dis.
1990;
161
381-396
- 4
Pizzo P A.
Management of fever in patients with cancer and treatment-induced neutropenia.
N Engl J Med.
1993;
328
1323-1332
- 5
Maschmeyer G, Link H, Hiddemann W. et al .
Empirische antimikrobielle Therapie bei neutropenischen Patienten. Ergebnisse einer
Studie der Arbeitsgruppe Infektionen in der Hämatologie der Paul-Ehrlich-Gesellschaft.
Med Klin.
1994;
89
114-123
- 6
Barloon T J, Galvin J R, Mori M. et al .
High-resolution ultrafast chest CT in the clinical management of febrile bone marrow
transplant patients with normal or nonspecific chest roentgenogramms.
Chest.
1991;
99
928-933
- 7
Klein J O, Mortimer E A.
Use of pneumococcal vaccine in children.
Pediatrics.
1978;
61
312-322
- 8
Bridgen M L, Patullo A L.
Prevention and management of overwhelming postsplenectomy infection - An update.
Crit Care Med.
1999;
27
836-842
- 9
Heffelfinger J D, Dowell S F, Jorgensen J H. et al .
Management of communnity-acquired pneumonia in the era of pneumococcal resistance.
Arch Intern Med.
2000;
160
1399-1408
- 10
Co-operative group for the study of immunoglobulin in chronic lymphocytic leukaemia
.
Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic
leukaemia.
N Engl J Med.
1988;
319
902-907
- 11
Griffiths H, Brennan V, Lea J.
Crossover study of Immunoglobulin replacement therapy in patients with low-grade-B-cell
tumors.
Blood.
1989;
73
366-368
- 12
Boughton B J, Jackson N, Lim S. et al .
Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic
lymphocytic leukaemia and secondary hypogammaglobulinaenia.
Clin Lab Haematol.
1995;
17
75-80
- 13
Molica S, Musto P, Chiurazzi F.
Prophylaxis against infections with low-dose intravenous immunoglobulins in chronic
lymphocytic leukemia. Results of a crossover study.
Haematologica.
1996;
81
121-126
- 14 Schedel I. Application of immunoglobulin preparations in multiple myeloma. In:
Morell A, Nydegger UE. Clinical use of immunoglobulins. New York: Academic Press 1986:
123-132
- 15
Pirofsky B, Kinzey D M.
Intravenous immune globulins. A review of their use in selected immunodeficiency and
autoimmune diseases.
Drugs.
1992;
43
6-14
- 16
Wahn V, Eibl M, Spaith P.
Anwendung polyvalenter intravenöser Immunglobuline in der Therapie.
Mschr Kinderheilkd.
1999;
147
293-297
- 17
Carratala J, Roson B, Fernandez-Sevilla A. et al .
Bacteremic Pneumonia in Neutropenic Patients with Cancer.
Arch Intern Med.
1998;
158
868-872
- 18
Hughes W T, Armstrong D, Bodey G P.
Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained
fever.
Clin Infect Dis.
1997;
25
551-573
- 19
Kuhlmann J E, Fishman E, Siegelman S.
Invasive pulmonary aspergillosis in acute leukemia: characteristic findings in CT,
the CT halo sign, and the role of CT in early diagnosis.
Radiology.
1985;
157
611-619
- 20
Heussel C, Kauczor H, Heussel G.
Early detection of pneumonia in febrile neutropenic patients: Use of thin-section
CT.
Am J Roentgenol.
1997;
169
1347-1353
- 21
Shelhammer J H, Toews G B, Masur H. et al .
Respiratory disease in the immunosuppressed patient.
Ann Intern Med.
1992;
117
415-431
- 22
Sickles E, Young V, Greene W.
Pneumonia in acute leukemia.
Ann Intern Med.
1973;
79
528-534
- 23
Stover D E, Zaman M B, Hajdu S I. et al .
Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed
host.
Ann Intern Med.
1984;
101
1-7
- 24
Saito H, Anaissie E J, Morice R C. et al .
Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with
acute leukemia.
Chest.
1988;
94
745-749
- 25
Marra R, Pagano L, Pagliari G. et al .
The yield of bronchoalveolar lavage in the etiological diagnosis of pneumonia in leukemia
and lymphoma patients.
Eur J Hematol.
1993;
51
256-258
- 26
Ewig S, Glasmacher A, Ulrich B. et al .
Pulmonary infiltrates in neutropenic patients with acute leukemia during chemotherapy:
outcome and prognostic factors.
Chest.
1998;
114
444-451
- 27
Ewig S, Torres A, Riquelme R. et al .
Pulmonary complications in patients with haematologic malignancies treated at a respiratory
ICU.
Eur Respir J.
1998;
12
116-122
- 28
von Eiff M, Zühlsdorf M, Roos N. et al .
Pulmonary infiltrates in patients with hematologic malignancies Clinical usefulness
of non-invasive bronchoscopic procedures.
Eur J Haematol.
1995;
54
157-162
- 29
Rano A, Agusti C, Jimenez P. et al .
Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach
using non-invasive and bronchoscopic procedures.
Thorax.
2001;
56
379-387
- 30
Antonelli M, Conti G, Riccioni L. et al .
Noninvasive positive-pressure ventilation via face mask during bronchoscopy with BAL
in high-risk hypoxemic patients.
Chest.
1996;
110
724-728
- 31
Pennington J E, Feldman N T.
Pulmonary infiltrates and fever in patients with hematologic malignancy. Assessment
of transbronchial biopsy.
Am J Med.
1977;
62
581-587
- 32
Phillips M J, Knight R K, Green M.
Fibreoptic bronchoscopy and diagnosis of pulmonary lesions in lymphoma and leukemia.
Thorax.
1980;
35
19-25
- 33
Cazzadori A, Di Perri G, Todeschini G. et al .
Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised
patients.
Chest.
1995;
107
101-105
- 34
Wong P W, Stefanec T, Brown K. et al .
Role of fine-needle aspirates of focal lung lesions in patients with hematologic malignancies.
Chest.
2002;
121
527-532
- 35
White D A, Wong P W, Downey R.
The Utility of Open Lung Biopsy in patients with hematologic malignancies.
Am J Respir Crit Care Med.
2000;
161
723-729
- 36
von Eiff M, Zühlsdorf M, Roos N. et al .
Pulmonary fungal infections in patients with hematological malignancies - diagnostic
approaches.
Ann Hematol.
1995;
70
135-141
- 37
Kahn F W, Jones J M, England D M.
The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis.
Am J Clin Pathol.
1986;
86
518-523
- 38
Glasmacher A, Marklein G, Just-Nübling G. et al .
Diagnostik invasiver Mykosen bei neutropenischen Patienten mit hämatologischen Systemerkrankungen.
Dtsch Med Wschr.
1998;
123
157-160
- 39
Horvath J, Dummer S.
The use of respiratory tract cultures in the diagnosis of invasive aspergillosis.
Am J Med.
1996;
100
171-178
- 40
Sulahian A, Taboluret M, Ribaud P.
Comparison of an enzyme immunoassay and latex agglutination test for detection of
galactomannan in the diagnosis of aspergillosis.
Eur J Clin Microbiol Infect Dis.
1996;
15
139-145
- 41
Peters S G, Meadows J A, Gracey D R.
Outcome of respiratory failure in hematologic malignancy.
Chest.
1988;
94
99-102
- 42
Ramphal R.
Is monotherapy for febrile neutropenia still a viable alternative?.
Clin Infect Dis.
1999;
29
508-514
- 43
Maschmeyer G, Link H, Hiddemann W. et al .
Pulmonary infiltrations in febrile patients with neutropenia.
Cancer.
1994;
73
2296-2304
- 44
Maschmeyer G, Beinert T, Buchheidt D. et al .
Diagnostik und Therapie von Lungeninfiltraten bei febrilen neutropenischen Patienten.
Dtsch Med Wschr.
1999;
124
S18-S23
- 45 Rubin R H, Young L S. Clinical approach to infection in the compromised host. New
York3: Plenum Publishers 1994: 629-705
- 46
Acrasoy S M, Kotloff R M.
Lung transplantation.
N Engl J Med.
1999;
14
1081-1091
- 47
Kramer M R, Marshall S E, Starnes V A. et al .
Infectious complications after heart lung and single lung transplantation.
Chest.
1993;
104
681-685
- 48
Horvarth J, Dummer S, Loyd J. et al .
Infection in the transplanted and native lung after single lung transplantation.
Chest.
1993;
104
681-685
- 49
Paradis I L, Williams P.
Infection after lung transplantation.
Semin Respir Infect.
1993;
8
207-215
- 50
Ho M.
Advances in understanding cytomegalovirus infection after transplantation.
Transplant Proc.
1994;
26
7-11
- 51
Paterson D, Singh N.
Invasive aspergillosis in transplant recipients.
Medicine.
1999;
78
123-138
- 52
Fishman J A, Rubin R H.
Infection in organ-transplant recipients.
N Engl J Med.
1998;
338
1741-1751
- 53
Westney G E, Kesten S, DeHoyos A. et al .
Aspergillus infection in single and double lung transplant recipients.
Transplantation.
1996;
61
915-919
- 54
Keenan R J, Lega M E, Dummer J S.
Cytomegalovirus serologic status and postoperative infection correlated with risk
of developing chronic rejection after pulmonary transplantation.
Transplantation.
1991;
51
433
- 55
O'Brian J D, Ettinger N A.
Pulmonary complications of liver transplantation.
Clin Chest Med.
1996;
17
99-114
- 56
Hohlfeld J, Niedermeyer J, Hamm H. et al .
Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients.
J Heart Lung Transplant.
1996;
15
888-894
- 57
Kesten S, Chaparro C.
Mycobacterial infections in lung transplant recipients.
Chest.
1999;
115
741-745
- 58
Malouf M A, Glanville A R.
The Spectrum of Mycobacterial infection after lung transplantation.
Am J Respir Crit Care Med.
1999;
160
1611-1616
- 59
Sternberg R I, Baughman R P, Dohn M N. et al .
Utility of bronchoalveolar lavage in assessing pneumonia in immunosuppressed renal
transplant recipients.
Am J Med.
1993;
95
358-364
- 60
Egan J J, Barber L, Lomax J.
Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for
predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients.
Thorax.
1995;
50
59
- 61
Humar A, Gregson D, Caliendo A M. et al .
Clinical utility of quantitative cytomegalovirus viral load determination for pedicting
cytomegalovirus disease in liver transplant recipients.
Transplantation.
1999;
68
1305-1311
- 62
Caillot D, Casanovas O, Bernard A.
Improved management of invasive pulmonary in neutropenic patients using early thoracic
computed tomographic scan and surgery.
J Clin Oncol.
1997;
5
139-147
- 63
Johnson P C, Hogg K M, Sarosi G A.
The rapid diagnosis of pulmonary infections in solid organ transplant recipients.
Semin Respir Infect.
1990;
5
2-9
- 64
Torres A, Ewig S, Insausti J. et al .
Etiology and microbial patterns of pulmonary infiltrates in patients with orthotopic
liver transplantation.
Chest.
2000;
117
494-502
- 65
Dichter J R, Stewart J, Shelhammer J H.
Approach to the immunocompromised host with pulmonary infiltrates.
Hematol/Oncol Clin North Am.
1993;
7
887-912
- 66
Reichenberger F, Habicht J, Matt P. et al .
Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis.
Bone Marrow Transplant.
1999;
24
1195-1199
- 67
Pomerance A, Madden B, Burke M M. et al .
Transbronchial biosy in heart and lung transplantations: clinicopathologic correlations.
J Heart Lung Transplant.
1995;
14
761-773
- 68
Boehler A.
Prospective study of the value of transbronchial lung biopsy after lung transplantation.
Eur Respir J.
1996;
4
658-662
- 69
Trulock E P.
Flexible bronchoscopy in lung transplantation.
Clin Chest Med.
1999;
20
77-87
- 70
Paterson D, Singh N, Gayowski T.
Pulmonary nodules in liver transplant recipients.
Medicine.
1998;
77
50-58
- 71
Bart M E, Webber B L, Wesley R A.
Prospective evaluation of aspiration needle, cutting needle, transbronchial, and open
lung biopsy in patients with pulmonary infiltrates.
Ann Thorac Surg.
1981;
32
146-153
- 72
Gregg C R.
Drug interactions and anti-infective therapies.
Am J Med.
1999;
106
227-237
- 73
Kim J S, Lee K S, Koh E M. et al .
Thoracic involvement of systemic lupus erythematodes: clinical, pathologic, and radiologic
findings.
J Comput Assist Tomogr.
2000;
24
9-18
- 74
Murin S, Wiedemann H P, Matthay R A.
Pulmonary manifestations of systemic lupus erythematodes.
Chest.
1998;
19
641-665
- 75
Santamauro J T, White D A.
Respiratory infections in HIV-negative immunocompromised patients.
Curr Opin Pulm Med.
1996;
2
253-258
- 76
Godeau B, Coulant-Perrone V, Huong D I. et al .
Pneumocystis carinii pneumonia in the course of connective tissue disease: report
of 34 cases.
J Rheumatol.
1994;
21
246-251
- 77
Mok C C, Yuen K Y, Lau C S.
Nocardiosis in systemic lupus erythematodes.
Semin Arthritis Rheum.
1997;
26
675-680
- 78
Feng P H, Tang T H.
Tuberculosis in patients with systemic lupus erythematodes.
Ann Rheum Dis.
1982;
41
11-18
- 79
Maini R, St Clair E W, Breedvelt F. et al .
Infliximab or placebo in rheumatoid arthritis patients receiving concomittant methotrexate:
a randomised phase III trial.
Lancet.
1999;
354
1932-1939
- 80
Sullivan W D, Hurst D J, Harmon C F.
A prospective evaluation emphasizing pulmonary involvement in patients with mixed
connective tissue disease.
Medicine.
1984;
63
92-107
- 81
Fenlon H M, Doran M, Sant S M.
High resolution chest-CT in systemic lupus erythematodes.
Am J Roentgenol.
1996;
166
301-306
- 82
Evans S A, Hopkinson N D, Kinnear W J.
Respiratory disease in systemic lupus erythematodes: correlation with results of laboratory
tests and histological appearance of muscle biopsy specimens.
Thorax.
1992;
47
957-967
- 83
Flabouris A, Myburgh J.
The utility of open lung biopsy in patients requiring mechanical ventilation.
Chest.
1999;
115
811-817
- 84
Agostini C, Trentin L, Zambello and Semenzato G.
HIV-1 and the lung.
Am Rev Respir Dis.
1993;
147
1038-1049
- 85
Bofil M, Lipman M, McLaughlin J E. et al .
Changes in lung lymphocyte populations reflect those seen in peripheral blood in HIV-1
positive individuals.
Eur Respir J.
1998;
11
548-553
- 86
Clerici M, Shearer G M.
The Th1-Th2 hypothesis of HIV infection: new insights.
Immunol Today.
1994;
15
575-581
- 87
USHS/IDSA Prevention of Opportunistic Infections Working Group .
Guidelines for the prevention of opportunistic infections in persons infected with
human immundodeficiency virus.
Ann Intern Med.
1999;
131
873-896
- 88
Mayaud C, Cadranel J.
AIDS and the lung in a changing world.
Thorax.
2001;
56
423-426
- 89 Bericht des Aids-Zentrums im Robert Koch-Institut über aktuelle epidemiologische
Daten, Quartalsbericht IV/98. Berlin 1999
- 90
Wallace J M, Hansen N I, Lavange L. et al .
Respiratory disease trends in the pulmonary complications of HIV infected study cohort.
Am J Respir Crit Care Med.
1997;
155
72-80
- 91
Brodt H, Kamps B, Gute P. et al .
Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination
therapy.
AIDS.
1997;
11
1731-1738
- 92
Sullivan J H, Moore R D, Keruly J C. et al .
Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients
with advanced HIV infection.
Am J Respir Crit Care Med.
2000;
162
64-67
- 93
Feldman C, Glatthaar M, Morar R. et al .
Bacteremic pneumococcal pneumonia in HIV-seropositive and HIV-seronegative adults.
Chest.
1999;
116
107-114
- 94
Baughman R P, Dohn M, Frame P.
The continuing utillity of bronchoalveolar lavage to diagnose opportunistic infection
in AIDS patients.
Am J Med.
1994;
97
515 -525
- 95
Koch A, Kothe H, Braun J. et al .
Inzidenz bakterieller Pneumonien bei HIV-positiven Patienten unter Co-trimoxazol oder
Pentamidin.
Pneumologie.
1998;
52
614-621
- 96
Miller R F, Foley N M, Kessel D. et al .
Community acquired lobar pneumonia in patients with HIV infection and AIDS.
Thorax.
1994;
49
367-368
- 97
Afessa B, Green W, Chiao J. et al .
Pulmonary complications of HIV-infection.
Chest.
1998;
113
1225-1229
- 98
Waxmann A, Goldie S, Brett-Smith H. et al .
Cytomegalovirus as a primary pulmonary pathogen in AIDS.
Chest.
1997;
111
128-134
- 99
Mylonakis E, Barlam T F, Flanigan T. et al .
Pulmonary aspergillosis and invasive disease in AIDS.
Chest.
1998;
114
251-262
- 100
Janoff E N, O'Brien J, Thompson P. et al .
Streptococcus pneumoniae colonization, bacteremia and immune response among persons
with human immunodeficiency virus infection.
J Infect Dis.
1993;
167
49-56
- 101
De Gracia J, Miravitlles M, Mayordomo C. et al .
Empiric treatments impair the diagnostic yield of BAL in HIV-positive patients.
Chest.
1997;
111
1180-1186
- 102
Weldon-Linne C M, Phone D P, Bourassa R.
Bronchoscopy specimens in adults with AIDS.
Chest.
1990;
98
24-28
- 103
Cadranel J, Gillet-Juvin K, Antoine M. et al .
Site-directed bronchoalveolar lavage and transbronchial biopsy in HIV-infected patients
with pneumonia.
Am J Respir Crit Care Med.
1995;
152
1103-1106
- 104
Caiffa W T, Graham N MH, Vlahov D.
Bacterial pneumonia in adult populations with Human Immundeficiency Virus infection.
Am J Epidemiol.
1993;
138
909-922
- 105
Ewig S, Nachtsheim K H, Seuffert H M. et al .
Protected bronchoalveolar lavage for the diagnosis of HIV-associated pneumonia.
J Bronchol.
1998;
5
25-33
- 106
Jules-Elysee K M, Stover D E, Zaman M B. et al .
Aerosolized pentamidine: Effect on diagnosis and presentation of Pneumocystis carinii
pneumonia.
Ann Intern Med.
1990;
112
750-757
- 107
Schlatter C E, Kuster H, Lüthy R. et al .
Sputumuntersuchung zur Diagnostik der Pneumocyctis-carinii-Pneumonie bei HIV-Infizierten.
Dtsch Med Wschr.
1994;
119
1151-1155
- 108
Schaberg T, Dalhoff K, Ewig S. et al .
Empfehlungen zur Therapie der ambulant erworbenen Pneumonie.
Pneumologie.
1998;
52
450-462
- 109
Baron A D, Hollander H.
Pseudomonas aeruginosa bronchopulmonary infection in late Human Immunodeficiency Virus
disease.
Am Rev Respir Dis.
1993;
148
992-996
- 110
Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose .
Richtlinien zur medikamentösen Behandlung der Tuberkulose im Erwachsenen- und Kindesalter.
Pneumologie.
2001;
55
494-511
- 111 Schaberg T. HIV und Tuberkulose. In: Konietzko N, Loddenkemper R (Hrsg): Tuberkulose.
Stuttgart: Thieme Verlag 1999: 199-214
- 112
Burman W J, Jones B E.
Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy.
Am J Respir Crit Care Med.
2001;
164
7-12
- 113
Gordin F M, Sullam P M, Shafran S D. et al .
A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin
and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
Clin Infect Dis.
1999;
28
1080-1085
- 114
Glasmacher A, Just-Nübling G, Molitor E.
Therapie invasiver Mykosen bei neutropenischen Patienten mit hämatologischen Systemerkrankungen.
Dtsch Med Wschr.
1998;
123
191-194
- 115
Walsh T J, Finberg R W, Arndt C. et al .
Liposomal amphotericin B for empirical therapy in patients with persistent fever and
neutropenia.
N Engl J Med.
1999;
340
764-771
- 116
Rex J H, Walsh T J, Sobel J D. et al .
Practice guidelines for the treatment of candidiasis.
Clin Infect Dis.
2000;
30
662-678
- 117
Bodey G P.
The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised
patients with cancer.
Am J Med.
2002;
112
380-385
- 118
Denning D W, Lee J Y, Hosttler J S.
Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis.
Am J Med.
1994;
97
135 -144
- 119
Denning D W.
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
Clin Infect Dis.
2002;
34
563-571
- 120
Arathoon E G.
Randomized, double blind, multicenter study of caspofungin versus amphotericin B for
treatment of oropharyngeal and esophageal candidiasis.
Antimicrob Agents Chemother.
2002;
46
451-457
- 121
Reichenberger F, Habicht J, Kaim A. et al .
Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic
diseases.
Am J Respir Crit Care Med.
1998;
158
885-890
- 122
Sattler F R, Cowan R, Nielsen D M. et al .
Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis
carinii pneumonia in the acquired immunodeficiency syndrome.
Ann Intern Med.
1988;
109
280-287
- 123
Hughes W, Leoung G, Kramer F. et al .
Comparison of Atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis
carinii pneumonia in patients with AIDS.
N Engl J Med.
1993;
328
1521-1527
- 124
Safrin S, Lee B L, Sande M A.
Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii
pneumonia in AIDS patients is associated with an increased risk of therapeutic failure
and death.
J Infect Dis.
1994;
170
912-917
- 125
Conte J E, Chernoff D, Feigal D W. et al .
Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in
AIDS.
Ann Intern Med.
1990;
113
203-209
- 126
Medina I, Mills J, Leoung G. et al .
Oral therapy for Pneumocystis carinii pneumonia in the acquired immonodeficiency syndrome.
N Engl J Med.
1990;
323
776-782
- 127
Bozzette S A, Sattler F R, Chiu J. et al .
A controlled trial of early adjunctive treatment with corticosteroids for Pneumocyctis
carinii pneumonia in the acquired immunodeficiency syndrome.
N Engl J Med.
1990;
323
1451-1457
- 128
Pareja J G, Garland R, Koziel H.
Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia.
Chest.
1998;
113
1215-1224
- 129
Blanshard C, Benhamou Y, Dohin E. et al .
Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet
and ganciclovir: A randomized comparison.
J Infect Dis.
1995;
172
622-628
- 130
Hecht D W, Snydman D R, Crumpacker C S. et al .
Ganciclovir for treatment of renal transplant - associated primary cytomegalovirus
pneumonia.
J Infect Dis.
1988;
157
187-190
- 131
Martin D F, Sierra-Madero J, Walmsley S. et al .
A controlled trial of valganciclovir as induction therapy for Cytomegalovirus Retinitis.
N Engl J Med.
2002;
346
1119-1126
- 132
Kern W V, Beyer J, Böhme A. et al .
Infektionsprophylaxe bei neutropenischen Patienten.
Dtsch Med Wschr.
125;
2000
1582-1588
- 133
Deutsch E, End A, Grimm M. et al .
Early bacterial infections in lung transplant recipients.
Chest.
1993;
104
1412-1416
- 134
Chaparro C, Kesten S.
Infections in lung transplant recipients.
Clin Chest Med.
1997;
18
339-351
- 135
Corris P A.
Prophylaxis post-transplant. The role of monitoring surveillance bronchoscopy and
antimicrobials.
Clin Chest Med.
1997;
18
311-318
- 136
STIKO/Ständige Impfkommission .
Impfempfehlungen der Ständigen Impfkommission am Robert Koch-Institut.
Epidemiologisches Bulletin.
2000;
2
9-20
- 137
Gebo K A, Moore R D, Keruly J C. et al .
Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients.
J Infect Dis.
1996;
173
857-862
- 138
Ammann A J, Addiego J, Wara D W.
Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia
and patients with splenectomy.
N Engl J Med.
1977;
297
897-900
- 139
Chattopadhyay B.
Splenectomy, pneumococcal vaccination and antibiotic prophylaxis.
Br J Hosp Med.
1989;
41
172-174
- 140
Funk E M, Schlimok G, Ehret W. et al .
Standortbestimmung der Impf-und Antibiotikaprophylaxe bei Splenektomie. Teil I: Erwachsene.
Chirurg.
1997;
68
586-590
- 141
Di Padova F, Durig M, Wadstrom J. et al .
Role of spleen in immune response to polyvalent pneumococcal vaccine.
Br Med J.
1983;
287
1829-1832
- 142
ATS/CDC Statement Committee on Latent Tuberculosis Infection .
Targeted tuberculin testing and treatment of latent tuberculosis infection.
MMWR.
2000;
49
1-51
- 143
Gordin F, Chaisson R E, Matts J P. et al .
Rifampin and Pyrazinamide vs Isoniazid for prevention of tuberculosis in HIV-infected
persons.
JAMA.
2000;
283
1445-1449
- 144
American Thoracic Society .
Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide
for latent tuberculosis infection, and revisions in American Thoracic Society /CDC
recommendations - United States 2001.
Am J Respir Crit Care Med.
2001;
164
1319-1320
- 145
Pierce M, Crampton S, Henry D. et al .
A randomized trial of clarithromycin as prophylaxis against disseminaed Mycobacterium
avium complex infection in patients with advanced acquired immunodeficiency syndrome.
N Engl J Med.
1996;
335
384-391
- 146
Havlir D V, Dube M P, Sattler F R. et al .
Prophylaxis against disseminated Mycobacterium avium complex with weekly Azithromycin,
daily Rifabutin, or both.
N Engl J Med.
1996;
335
392-398
- 147
Gryzan S, Paradis I L, Zeevi A. et al .
Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation.
Implications for lung defense and allograft survival.
Am Rev Respir Dis.
1988;
137
1268-1274
- 148
Gordon S M, LaRosa S P, Kalmadi S. et al .
Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients
ever be discontinued?.
Clin Inf Dis.
1999;
28
240-246
- 149
Olsen S L, Renlund D G, O’Conell J B.
Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim-sulfamethoxazole.
Transplantation.
1993;
56
359-362
- 150
Fishman J A.
Pneumocystis carinii and parasitic infections in transplantation.
Infect Dis Clin North Am.
1995;
9
1045-1047
- 151
Schneider M E, Hoepelman A IM, Eeftinck Schattenkerk J KM. et al .
A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as
primary prophylaxis against pneumocystis carinii pneumonia in patients with human
immunodeficiency virus infection.
N Engl J Med.
1992;
327
1836-1840
- 152
Bozzette S A, Finkelstein D M, Spector S A.
A randomized trial of three antipneumocystis agents in patients with advanced human
immunodeficiency virus infection.
N Engl J M.
1995;
332
693-699
- 153 Hill H E, Wallace M, Kennedy C. Prophylaxis of Pneumocystis carinii pneumonia
with dapsone; an evaluation of toxicity and cross-reactivity with trimethoprim-sulfamethoxazole. Amsterdam:
International Conference on AIDS 1992 PoB 3304
- 154
Bucher H C, Griffith L l, Guyatt G H. et al .
Meta-analyses of prophylactic treatments against PCP and Toxoplasma encephalitis in
HIV-infected patients.
J Acquir Immune Defic Syndr Hum Retrovirol.
1997;
15
104-114
- 155
Vernovsky I, Dellaripa P F.
Pneumocystis carinii pneumonia prophylaxis in patients with rheumatic diseases undergoing
immunsuppressive therapy.
J Clin Rheumatol.
2000;
6
94-101
- 156
Paradowski L J.
Saprophytic fungal infections and lung transplantation - revisited.
J Heart Lung Transplant.
- 157
Duncan S R, Grgurich W F, Iacono A T. et al .
A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.
Am J Respir Crit Care Med.
1994;
150
146-152
- 158
Calvo V, Borro J M, Morales P. et al .
Antifungal prophylaxis during the early postoperative period of lung transplantation.
Chest.
1999;
115
1301-1304
- 159
Hamacher J, Spiliopoulos A, Kurt A M. et al .
Pre-emptive therapy with azoles in lung transplant patients.
Eur Respir J.
1999;
13
180-186
- 160
Duncan S R, Gregurich W F, Iacono A T. et al .
A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.
Am J Respir Crit Care Med.
1994;
150
146-152
- 161
Lowance D, Neumayer H H, Legendre C M.
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation.
N Engl J Med.
1999;
340
1462-1470
- 162
Gutierrez C A, Chaparro C, Krajden M. et al .
Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune
globulin.
Chest.
1998;
113
924-932
- 163
Gane E, Saliba F, Valdecasas G J.
Randomized trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus
disease in liver transplant recipients.
Lancet.
1997;
350
1729-1733
- 164
Kusne S, Grossi P, Irish W. et al .
Cytomegalovirus pp65 antigenemia as a guide for preemptive therapy: a cost effective
strategy for prevention of cytomegalovirus disease in adult liver transplant recipients.
Transplantation.
1999;
68
1125-1131
- 165
Egan J J, Lomax J, Barber L. et al .
Preemptive treatment for the prevention of cytomegalovirus disease in lung and heart
transplant recipients.
Transplantation.
1998;
65
747-752
- 166
Singh N, Paterson D L, Gayowski T. et al .
Cytomegalovirus antigenemia directed pre-emptive prophylaxis with oral versus i. v.
ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients:
a randomized, controlled trial.
Transplantation.
2000;
15
717-722
- 167
Feinberg J E, Hurwitz S, Cooper D. et al .
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease
in patients with advanced human immunodeficciency virus infections.
J Infect Dis.
1998;
177
48-56
- 168
Freund S, Wagner D, Pethig K. et al .
Influenza vaccination in heart transplant recipients.
J Heart Lung Transplant.
1999;
18
220-225
- 169
Gross P A, Hermogenes A W, Sacks H S. et al .
The efficacy of influenza vaccine in elderly persons: a metaanalysis and review of
the literature.
Ann Int Med.
1995;
123
518-527
- 170
Tasker S A, Treanor J J, Paxton W B. et al .
Efficacy of influenza vaccination in HIV-infected persons: a randomized, double-blind,
placebo-controlled trial.
Ann Intern Med.
1999;
131
430-433
Prof. Dr. med. K. Dalhoff
Medizinische Klinik III, Universitätsklinikum Lübeck
Ratzeburger Allee 160
23538 Lübeck
Email: klaus.dalhoff@medinf.mu-luebeck.de
